AIM
CNMD icon

Aigen Investment Management’s CONMED CNMD Stock Holding History

Aigen Investment Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,249
Closed -$416K – 568
2025
Q4 		$416K Buy
10,249
+4,818
+89% +$210K 0.1% 276
2025
Q3 		$255K Buy
+5,431
New +$282K 0.04% 586
2024
Q4 		– Sell
-6,281
Closed -$452K – 770
2024
Q3 		$452K Buy
+6,281
New +$443K 0.09% 350
2024
Q2 		– Sell
-3,642
Closed -$292K – 812
2024
Q1 		$292K Buy
+3,642
New +$325K 0.06% 443
2022
Q4 		– Sell
-5,471
Closed -$439K – 565
2022
Q3 		$439K Buy
5,471
+1,393
+34% +$131K 0.06% 331
2022
Q2 		$391K Buy
+4,078
New +$489K 0.07% 349
2020
Q2 		– Sell
-11
Closed -$1K – 894
2020
Q1 		$1K Sell
11
-57
-84% -$5.26K ﹤0.01% 1218
2019
Q4 		$8K Buy
+68
New +$7.25K ﹤0.01% 975

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Aigen Investment Management's CNMD Position: Q1 2026 in Review

Aigen Investment Management sold out of CONMED (CNMD) in Q1 2026, closing a stake of 10,249 shares — an estimated $416K sold.

Aigen Investment Management first reported a position in CNMD in Q4 2019 and held it in 8 quarters. The position peaked at $452K in Q3 2024. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Aigen Investment Management reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • Aigen Investment Management sold 10,249 CONMED shares in Q1 2026, an estimated $416K.
  • Aigen Investment Management first reported a position in CONMED in Q4 2019 and held it in 8 quarters.
  • Aigen Investment Management's CONMED position peaked at $452K in Q3 2024.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.